nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—CYP1A1—Clobetasol propionate—psoriasis	0.176	0.261	CbGbCtD
Riluzole—CYP1A1—Methoxsalen—psoriasis	0.0926	0.137	CbGbCtD
Riluzole—CYP1A2—Clobetasol propionate—psoriasis	0.0787	0.116	CbGbCtD
Riluzole—CYP1A1—Cholecalciferol—psoriasis	0.0613	0.0907	CbGbCtD
Riluzole—ABCG2—Mycophenolate mofetil—psoriasis	0.0576	0.0852	CbGbCtD
Riluzole—ABCG2—Hydrocortisone—psoriasis	0.0462	0.0683	CbGbCtD
Riluzole—ABCG2—Cyclosporine—psoriasis	0.0437	0.0645	CbGbCtD
Riluzole—CYP1A2—Methoxsalen—psoriasis	0.0414	0.0611	CbGbCtD
Riluzole—ABCG2—Dexamethasone—psoriasis	0.0288	0.0425	CbGbCtD
Riluzole—CYP1A1—Dexamethasone—psoriasis	0.0265	0.0392	CbGbCtD
Riluzole—ABCG2—Methotrexate—psoriasis	0.0231	0.0342	CbGbCtD
Riluzole—SLC7A11—Betamethasone—Clobetasol propionate—psoriasis	0.000589	0.0968	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Clobetasol propionate—psoriasis	0.000589	0.0968	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Beclomethasone—psoriasis	0.000472	0.0775	CbGdCrCtD
Riluzole—SLC7A11—Betamethasone—Fluocinonide—psoriasis	0.000472	0.0775	CbGdCrCtD
Riluzole—SLC7A11—Betamethasone—Beclomethasone—psoriasis	0.000472	0.0775	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Fluocinonide—psoriasis	0.000472	0.0775	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.000458	0.0754	CbGdCrCtD
Riluzole—SLC7A11—Betamethasone—Fluocinolone Acetonide—psoriasis	0.000458	0.0754	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Hydrocortisone—psoriasis	0.000232	0.0381	CbGdCrCtD
Riluzole—SLC7A11—Betamethasone—Hydrocortisone—psoriasis	0.000232	0.0381	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Betamethasone—psoriasis	0.000215	0.0353	CbGdCrCtD
Riluzole—SLC7A11—Betamethasone—Dexamethasone—psoriasis	0.000215	0.0353	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Triamcinolone—psoriasis	0.00021	0.0345	CbGdCrCtD
Riluzole—SLC7A11—Betamethasone—Triamcinolone—psoriasis	0.00021	0.0345	CbGdCrCtD
Riluzole—SLC7A11—Betamethasone—Prednisone—psoriasis	0.000199	0.0328	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Prednisone—psoriasis	0.000199	0.0328	CbGdCrCtD
Riluzole—SLC7A11—Betamethasone—Prednisolone—psoriasis	0.000195	0.032	CbGdCrCtD
Riluzole—SLC7A11—Dexamethasone—Prednisolone—psoriasis	0.000195	0.032	CbGdCrCtD
Riluzole—Discomfort—Betamethasone—psoriasis	5.46e-05	0.000172	CcSEcCtD
Riluzole—Dyspepsia—Hydrocortisone—psoriasis	5.46e-05	0.000172	CcSEcCtD
Riluzole—Haemoglobin—Methotrexate—psoriasis	5.46e-05	0.000172	CcSEcCtD
Riluzole—Rash—Mycophenolic acid—psoriasis	5.44e-05	0.000171	CcSEcCtD
Riluzole—Dermatitis—Mycophenolic acid—psoriasis	5.44e-05	0.000171	CcSEcCtD
Riluzole—Pain—Prednisolone—psoriasis	5.43e-05	0.000171	CcSEcCtD
Riluzole—Haemorrhage—Methotrexate—psoriasis	5.43e-05	0.000171	CcSEcCtD
Riluzole—Hepatitis—Methotrexate—psoriasis	5.43e-05	0.000171	CcSEcCtD
Riluzole—Urticaria—Mycophenolate mofetil—psoriasis	5.41e-05	0.00017	CcSEcCtD
Riluzole—Headache—Mycophenolic acid—psoriasis	5.41e-05	0.00017	CcSEcCtD
Riluzole—Decreased appetite—Hydrocortisone—psoriasis	5.39e-05	0.00017	CcSEcCtD
Riluzole—Pharyngitis—Methotrexate—psoriasis	5.39e-05	0.00017	CcSEcCtD
Riluzole—Body temperature increased—Mycophenolate mofetil—psoriasis	5.38e-05	0.00017	CcSEcCtD
Riluzole—Abdominal pain—Mycophenolate mofetil—psoriasis	5.38e-05	0.00017	CcSEcCtD
Riluzole—Urinary tract disorder—Methotrexate—psoriasis	5.36e-05	0.000169	CcSEcCtD
Riluzole—Gastrointestinal disorder—Hydrocortisone—psoriasis	5.36e-05	0.000169	CcSEcCtD
Riluzole—Fatigue—Hydrocortisone—psoriasis	5.35e-05	0.000168	CcSEcCtD
Riluzole—Urethral disorder—Methotrexate—psoriasis	5.32e-05	0.000168	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Triamcinolone—psoriasis	5.32e-05	0.000168	CcSEcCtD
Riluzole—Pain—Hydrocortisone—psoriasis	5.31e-05	0.000167	CcSEcCtD
Riluzole—Anaphylactic shock—Dexamethasone—psoriasis	5.3e-05	0.000167	CcSEcCtD
Riluzole—Oedema—Betamethasone—psoriasis	5.3e-05	0.000167	CcSEcCtD
Riluzole—Anaphylactic shock—Betamethasone—psoriasis	5.3e-05	0.000167	CcSEcCtD
Riluzole—Oedema—Dexamethasone—psoriasis	5.3e-05	0.000167	CcSEcCtD
Riluzole—Insomnia—Triamcinolone—psoriasis	5.28e-05	0.000166	CcSEcCtD
Riluzole—Infection—Dexamethasone—psoriasis	5.27e-05	0.000166	CcSEcCtD
Riluzole—Infection—Betamethasone—psoriasis	5.27e-05	0.000166	CcSEcCtD
Riluzole—Ill-defined disorder—Prednisone—psoriasis	5.25e-05	0.000165	CcSEcCtD
Riluzole—Paraesthesia—Triamcinolone—psoriasis	5.25e-05	0.000165	CcSEcCtD
Riluzole—Feeling abnormal—Prednisolone—psoriasis	5.24e-05	0.000165	CcSEcCtD
Riluzole—Anaemia—Prednisone—psoriasis	5.23e-05	0.000165	CcSEcCtD
Riluzole—Shock—Betamethasone—psoriasis	5.22e-05	0.000164	CcSEcCtD
Riluzole—Shock—Dexamethasone—psoriasis	5.22e-05	0.000164	CcSEcCtD
Riluzole—Dyspnoea—Triamcinolone—psoriasis	5.21e-05	0.000164	CcSEcCtD
Riluzole—Nervous system disorder—Dexamethasone—psoriasis	5.2e-05	0.000164	CcSEcCtD
Riluzole—Nervous system disorder—Betamethasone—psoriasis	5.2e-05	0.000164	CcSEcCtD
Riluzole—Agitation—Prednisone—psoriasis	5.2e-05	0.000164	CcSEcCtD
Riluzole—Thrombocytopenia—Dexamethasone—psoriasis	5.19e-05	0.000163	CcSEcCtD
Riluzole—Thrombocytopenia—Betamethasone—psoriasis	5.19e-05	0.000163	CcSEcCtD
Riluzole—Tachycardia—Betamethasone—psoriasis	5.17e-05	0.000163	CcSEcCtD
Riluzole—Tachycardia—Dexamethasone—psoriasis	5.17e-05	0.000163	CcSEcCtD
Riluzole—Angioedema—Prednisone—psoriasis	5.17e-05	0.000163	CcSEcCtD
Riluzole—Hypersensitivity—Cyclosporine—psoriasis	5.14e-05	0.000162	CcSEcCtD
Riluzole—Dyspepsia—Triamcinolone—psoriasis	5.14e-05	0.000162	CcSEcCtD
Riluzole—Erythema multiforme—Methotrexate—psoriasis	5.13e-05	0.000162	CcSEcCtD
Riluzole—Nausea—Mycophenolic acid—psoriasis	5.13e-05	0.000161	CcSEcCtD
Riluzole—Hyperhidrosis—Betamethasone—psoriasis	5.13e-05	0.000161	CcSEcCtD
Riluzole—Hyperhidrosis—Dexamethasone—psoriasis	5.13e-05	0.000161	CcSEcCtD
Riluzole—Feeling abnormal—Hydrocortisone—psoriasis	5.11e-05	0.000161	CcSEcCtD
Riluzole—Malaise—Prednisone—psoriasis	5.1e-05	0.000161	CcSEcCtD
Riluzole—Vertigo—Prednisone—psoriasis	5.08e-05	0.00016	CcSEcCtD
Riluzole—Eye disorder—Methotrexate—psoriasis	5.08e-05	0.00016	CcSEcCtD
Riluzole—Gastrointestinal pain—Hydrocortisone—psoriasis	5.07e-05	0.00016	CcSEcCtD
Riluzole—Syncope—Prednisone—psoriasis	5.07e-05	0.00016	CcSEcCtD
Riluzole—Anorexia—Dexamethasone—psoriasis	5.05e-05	0.000159	CcSEcCtD
Riluzole—Anorexia—Betamethasone—psoriasis	5.05e-05	0.000159	CcSEcCtD
Riluzole—Urticaria—Prednisolone—psoriasis	5.05e-05	0.000159	CcSEcCtD
Riluzole—Cardiac disorder—Methotrexate—psoriasis	5.04e-05	0.000159	CcSEcCtD
Riluzole—Fatigue—Triamcinolone—psoriasis	5.04e-05	0.000159	CcSEcCtD
Riluzole—Hypersensitivity—Mycophenolate mofetil—psoriasis	5.02e-05	0.000158	CcSEcCtD
Riluzole—Asthenia—Cyclosporine—psoriasis	5.01e-05	0.000158	CcSEcCtD
Riluzole—Pain—Triamcinolone—psoriasis	5e-05	0.000157	CcSEcCtD
Riluzole—Loss of consciousness—Prednisone—psoriasis	4.97e-05	0.000157	CcSEcCtD
Riluzole—Hypotension—Betamethasone—psoriasis	4.95e-05	0.000156	CcSEcCtD
Riluzole—Hypotension—Dexamethasone—psoriasis	4.95e-05	0.000156	CcSEcCtD
Riluzole—Pruritus—Cyclosporine—psoriasis	4.94e-05	0.000156	CcSEcCtD
Riluzole—Urticaria—Hydrocortisone—psoriasis	4.93e-05	0.000155	CcSEcCtD
Riluzole—Angiopathy—Methotrexate—psoriasis	4.93e-05	0.000155	CcSEcCtD
Riluzole—Immune system disorder—Methotrexate—psoriasis	4.91e-05	0.000154	CcSEcCtD
Riluzole—Body temperature increased—Hydrocortisone—psoriasis	4.91e-05	0.000154	CcSEcCtD
Riluzole—Abdominal pain—Hydrocortisone—psoriasis	4.91e-05	0.000154	CcSEcCtD
Riluzole—Convulsion—Prednisone—psoriasis	4.9e-05	0.000154	CcSEcCtD
Riluzole—Mediastinal disorder—Methotrexate—psoriasis	4.89e-05	0.000154	CcSEcCtD
Riluzole—Asthenia—Mycophenolate mofetil—psoriasis	4.89e-05	0.000154	CcSEcCtD
Riluzole—Hypertension—Prednisone—psoriasis	4.88e-05	0.000154	CcSEcCtD
Riluzole—Chills—Methotrexate—psoriasis	4.87e-05	0.000153	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Betamethasone—psoriasis	4.83e-05	0.000152	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Dexamethasone—psoriasis	4.83e-05	0.000152	CcSEcCtD
Riluzole—Pruritus—Mycophenolate mofetil—psoriasis	4.82e-05	0.000152	CcSEcCtD
Riluzole—Arthralgia—Prednisone—psoriasis	4.82e-05	0.000152	CcSEcCtD
Riluzole—Myalgia—Prednisone—psoriasis	4.82e-05	0.000152	CcSEcCtD
Riluzole—Feeling abnormal—Triamcinolone—psoriasis	4.81e-05	0.000152	CcSEcCtD
Riluzole—Anxiety—Prednisone—psoriasis	4.8e-05	0.000151	CcSEcCtD
Riluzole—Alopecia—Methotrexate—psoriasis	4.8e-05	0.000151	CcSEcCtD
Riluzole—Insomnia—Betamethasone—psoriasis	4.79e-05	0.000151	CcSEcCtD
Riluzole—Insomnia—Dexamethasone—psoriasis	4.79e-05	0.000151	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	4.78e-05	0.000151	CcSEcCtD
Riluzole—Diarrhoea—Cyclosporine—psoriasis	4.78e-05	0.00015	CcSEcCtD
Riluzole—Paraesthesia—Dexamethasone—psoriasis	4.76e-05	0.00015	CcSEcCtD
Riluzole—Paraesthesia—Betamethasone—psoriasis	4.76e-05	0.00015	CcSEcCtD
Riluzole—Discomfort—Prednisone—psoriasis	4.76e-05	0.00015	CcSEcCtD
Riluzole—Mental disorder—Methotrexate—psoriasis	4.76e-05	0.00015	CcSEcCtD
Riluzole—Malnutrition—Methotrexate—psoriasis	4.73e-05	0.000149	CcSEcCtD
Riluzole—Hypersensitivity—Prednisolone—psoriasis	4.68e-05	0.000147	CcSEcCtD
Riluzole—Dyspepsia—Betamethasone—psoriasis	4.67e-05	0.000147	CcSEcCtD
Riluzole—Dyspepsia—Dexamethasone—psoriasis	4.67e-05	0.000147	CcSEcCtD
Riluzole—Diarrhoea—Mycophenolate mofetil—psoriasis	4.66e-05	0.000147	CcSEcCtD
Riluzole—Urticaria—Triamcinolone—psoriasis	4.64e-05	0.000146	CcSEcCtD
Riluzole—Dysgeusia—Methotrexate—psoriasis	4.63e-05	0.000146	CcSEcCtD
Riluzole—Body temperature increased—Triamcinolone—psoriasis	4.62e-05	0.000145	CcSEcCtD
Riluzole—Dizziness—Cyclosporine—psoriasis	4.62e-05	0.000145	CcSEcCtD
Riluzole—Oedema—Prednisone—psoriasis	4.62e-05	0.000145	CcSEcCtD
Riluzole—Anaphylactic shock—Prednisone—psoriasis	4.62e-05	0.000145	CcSEcCtD
Riluzole—Decreased appetite—Dexamethasone—psoriasis	4.61e-05	0.000145	CcSEcCtD
Riluzole—Decreased appetite—Betamethasone—psoriasis	4.61e-05	0.000145	CcSEcCtD
Riluzole—Infection—Prednisone—psoriasis	4.59e-05	0.000144	CcSEcCtD
Riluzole—Gastrointestinal disorder—Betamethasone—psoriasis	4.58e-05	0.000144	CcSEcCtD
Riluzole—Gastrointestinal disorder—Dexamethasone—psoriasis	4.58e-05	0.000144	CcSEcCtD
Riluzole—Back pain—Methotrexate—psoriasis	4.57e-05	0.000144	CcSEcCtD
Riluzole—Hypersensitivity—Hydrocortisone—psoriasis	4.57e-05	0.000144	CcSEcCtD
Riluzole—Fatigue—Betamethasone—psoriasis	4.57e-05	0.000144	CcSEcCtD
Riluzole—Fatigue—Dexamethasone—psoriasis	4.57e-05	0.000144	CcSEcCtD
Riluzole—Shock—Prednisone—psoriasis	4.54e-05	0.000143	CcSEcCtD
Riluzole—Pain—Dexamethasone—psoriasis	4.53e-05	0.000143	CcSEcCtD
Riluzole—Pain—Betamethasone—psoriasis	4.53e-05	0.000143	CcSEcCtD
Riluzole—Nervous system disorder—Prednisone—psoriasis	4.53e-05	0.000143	CcSEcCtD
Riluzole—Tachycardia—Prednisone—psoriasis	4.51e-05	0.000142	CcSEcCtD
Riluzole—Dizziness—Mycophenolate mofetil—psoriasis	4.5e-05	0.000142	CcSEcCtD
Riluzole—Skin disorder—Prednisone—psoriasis	4.48e-05	0.000141	CcSEcCtD
Riluzole—Hyperhidrosis—Prednisone—psoriasis	4.46e-05	0.000141	CcSEcCtD
Riluzole—Asthenia—Hydrocortisone—psoriasis	4.45e-05	0.00014	CcSEcCtD
Riluzole—Vomiting—Cyclosporine—psoriasis	4.44e-05	0.00014	CcSEcCtD
Riluzole—Rash—Cyclosporine—psoriasis	4.4e-05	0.000139	CcSEcCtD
Riluzole—Anorexia—Prednisone—psoriasis	4.4e-05	0.000139	CcSEcCtD
Riluzole—Dermatitis—Cyclosporine—psoriasis	4.4e-05	0.000139	CcSEcCtD
Riluzole—Pruritus—Hydrocortisone—psoriasis	4.39e-05	0.000138	CcSEcCtD
Riluzole—Ill-defined disorder—Methotrexate—psoriasis	4.39e-05	0.000138	CcSEcCtD
Riluzole—Headache—Cyclosporine—psoriasis	4.37e-05	0.000138	CcSEcCtD
Riluzole—Anaemia—Methotrexate—psoriasis	4.37e-05	0.000138	CcSEcCtD
Riluzole—Feeling abnormal—Dexamethasone—psoriasis	4.37e-05	0.000138	CcSEcCtD
Riluzole—Feeling abnormal—Betamethasone—psoriasis	4.37e-05	0.000138	CcSEcCtD
Riluzole—Gastrointestinal pain—Betamethasone—psoriasis	4.34e-05	0.000137	CcSEcCtD
Riluzole—Gastrointestinal pain—Dexamethasone—psoriasis	4.34e-05	0.000137	CcSEcCtD
Riluzole—Vomiting—Mycophenolate mofetil—psoriasis	4.33e-05	0.000136	CcSEcCtD
Riluzole—Hypersensitivity—Triamcinolone—psoriasis	4.3e-05	0.000136	CcSEcCtD
Riluzole—Rash—Mycophenolate mofetil—psoriasis	4.29e-05	0.000135	CcSEcCtD
Riluzole—Dermatitis—Mycophenolate mofetil—psoriasis	4.29e-05	0.000135	CcSEcCtD
Riluzole—Headache—Mycophenolate mofetil—psoriasis	4.27e-05	0.000134	CcSEcCtD
Riluzole—Malaise—Methotrexate—psoriasis	4.26e-05	0.000134	CcSEcCtD
Riluzole—Vertigo—Methotrexate—psoriasis	4.25e-05	0.000134	CcSEcCtD
Riluzole—Diarrhoea—Hydrocortisone—psoriasis	4.25e-05	0.000134	CcSEcCtD
Riluzole—Leukopenia—Methotrexate—psoriasis	4.23e-05	0.000133	CcSEcCtD
Riluzole—Urticaria—Dexamethasone—psoriasis	4.21e-05	0.000133	CcSEcCtD
Riluzole—Urticaria—Betamethasone—psoriasis	4.21e-05	0.000133	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Prednisone—psoriasis	4.21e-05	0.000132	CcSEcCtD
Riluzole—Dizziness—Prednisolone—psoriasis	4.2e-05	0.000132	CcSEcCtD
Riluzole—Asthenia—Triamcinolone—psoriasis	4.19e-05	0.000132	CcSEcCtD
Riluzole—Abdominal pain—Betamethasone—psoriasis	4.19e-05	0.000132	CcSEcCtD
Riluzole—Body temperature increased—Dexamethasone—psoriasis	4.19e-05	0.000132	CcSEcCtD
Riluzole—Abdominal pain—Dexamethasone—psoriasis	4.19e-05	0.000132	CcSEcCtD
Riluzole—Body temperature increased—Betamethasone—psoriasis	4.19e-05	0.000132	CcSEcCtD
Riluzole—Insomnia—Prednisone—psoriasis	4.18e-05	0.000132	CcSEcCtD
Riluzole—Nausea—Cyclosporine—psoriasis	4.15e-05	0.000131	CcSEcCtD
Riluzole—Paraesthesia—Prednisone—psoriasis	4.15e-05	0.000131	CcSEcCtD
Riluzole—Pruritus—Triamcinolone—psoriasis	4.13e-05	0.00013	CcSEcCtD
Riluzole—Cough—Methotrexate—psoriasis	4.13e-05	0.00013	CcSEcCtD
Riluzole—Dizziness—Hydrocortisone—psoriasis	4.1e-05	0.000129	CcSEcCtD
Riluzole—Convulsion—Methotrexate—psoriasis	4.1e-05	0.000129	CcSEcCtD
Riluzole—Dyspepsia—Prednisone—psoriasis	4.06e-05	0.000128	CcSEcCtD
Riluzole—Nausea—Mycophenolate mofetil—psoriasis	4.05e-05	0.000127	CcSEcCtD
Riluzole—Myalgia—Methotrexate—psoriasis	4.02e-05	0.000127	CcSEcCtD
Riluzole—Arthralgia—Methotrexate—psoriasis	4.02e-05	0.000127	CcSEcCtD
Riluzole—Chest pain—Methotrexate—psoriasis	4.02e-05	0.000127	CcSEcCtD
Riluzole—Decreased appetite—Prednisone—psoriasis	4.01e-05	0.000126	CcSEcCtD
Riluzole—Rash—Prednisolone—psoriasis	4.01e-05	0.000126	CcSEcCtD
Riluzole—Dermatitis—Prednisolone—psoriasis	4e-05	0.000126	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	4e-05	0.000126	CcSEcCtD
Riluzole—Fatigue—Prednisone—psoriasis	3.98e-05	0.000125	CcSEcCtD
Riluzole—Headache—Prednisolone—psoriasis	3.98e-05	0.000125	CcSEcCtD
Riluzole—Discomfort—Methotrexate—psoriasis	3.98e-05	0.000125	CcSEcCtD
Riluzole—Constipation—Prednisone—psoriasis	3.95e-05	0.000124	CcSEcCtD
Riluzole—Vomiting—Hydrocortisone—psoriasis	3.95e-05	0.000124	CcSEcCtD
Riluzole—Rash—Hydrocortisone—psoriasis	3.91e-05	0.000123	CcSEcCtD
Riluzole—Dermatitis—Hydrocortisone—psoriasis	3.91e-05	0.000123	CcSEcCtD
Riluzole—Confusional state—Methotrexate—psoriasis	3.89e-05	0.000123	CcSEcCtD
Riluzole—Headache—Hydrocortisone—psoriasis	3.89e-05	0.000122	CcSEcCtD
Riluzole—Dizziness—Triamcinolone—psoriasis	3.86e-05	0.000122	CcSEcCtD
Riluzole—Anaphylactic shock—Methotrexate—psoriasis	3.86e-05	0.000122	CcSEcCtD
Riluzole—Infection—Methotrexate—psoriasis	3.83e-05	0.000121	CcSEcCtD
Riluzole—Feeling abnormal—Prednisone—psoriasis	3.8e-05	0.00012	CcSEcCtD
Riluzole—Asthenia—Dexamethasone—psoriasis	3.8e-05	0.00012	CcSEcCtD
Riluzole—Asthenia—Betamethasone—psoriasis	3.8e-05	0.00012	CcSEcCtD
Riluzole—Nervous system disorder—Methotrexate—psoriasis	3.78e-05	0.000119	CcSEcCtD
Riluzole—Thrombocytopenia—Methotrexate—psoriasis	3.78e-05	0.000119	CcSEcCtD
Riluzole—Gastrointestinal pain—Prednisone—psoriasis	3.78e-05	0.000119	CcSEcCtD
Riluzole—Nausea—Prednisolone—psoriasis	3.77e-05	0.000119	CcSEcCtD
Riluzole—Pruritus—Betamethasone—psoriasis	3.75e-05	0.000118	CcSEcCtD
Riluzole—Pruritus—Dexamethasone—psoriasis	3.75e-05	0.000118	CcSEcCtD
Riluzole—Skin disorder—Methotrexate—psoriasis	3.75e-05	0.000118	CcSEcCtD
Riluzole—Hyperhidrosis—Methotrexate—psoriasis	3.73e-05	0.000117	CcSEcCtD
Riluzole—Vomiting—Triamcinolone—psoriasis	3.71e-05	0.000117	CcSEcCtD
Riluzole—Nausea—Hydrocortisone—psoriasis	3.69e-05	0.000116	CcSEcCtD
Riluzole—Rash—Triamcinolone—psoriasis	3.68e-05	0.000116	CcSEcCtD
Riluzole—Dermatitis—Triamcinolone—psoriasis	3.68e-05	0.000116	CcSEcCtD
Riluzole—Anorexia—Methotrexate—psoriasis	3.68e-05	0.000116	CcSEcCtD
Riluzole—Urticaria—Prednisone—psoriasis	3.67e-05	0.000116	CcSEcCtD
Riluzole—Headache—Triamcinolone—psoriasis	3.66e-05	0.000115	CcSEcCtD
Riluzole—Body temperature increased—Prednisone—psoriasis	3.65e-05	0.000115	CcSEcCtD
Riluzole—Abdominal pain—Prednisone—psoriasis	3.65e-05	0.000115	CcSEcCtD
Riluzole—Diarrhoea—Betamethasone—psoriasis	3.63e-05	0.000114	CcSEcCtD
Riluzole—Diarrhoea—Dexamethasone—psoriasis	3.63e-05	0.000114	CcSEcCtD
Riluzole—Hypotension—Methotrexate—psoriasis	3.61e-05	0.000114	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Methotrexate—psoriasis	3.52e-05	0.000111	CcSEcCtD
Riluzole—Dizziness—Dexamethasone—psoriasis	3.51e-05	0.00011	CcSEcCtD
Riluzole—Dizziness—Betamethasone—psoriasis	3.51e-05	0.00011	CcSEcCtD
Riluzole—Insomnia—Methotrexate—psoriasis	3.49e-05	0.00011	CcSEcCtD
Riluzole—Nausea—Triamcinolone—psoriasis	3.47e-05	0.000109	CcSEcCtD
Riluzole—Paraesthesia—Methotrexate—psoriasis	3.46e-05	0.000109	CcSEcCtD
Riluzole—Dyspnoea—Methotrexate—psoriasis	3.44e-05	0.000108	CcSEcCtD
Riluzole—Somnolence—Methotrexate—psoriasis	3.43e-05	0.000108	CcSEcCtD
Riluzole—Hypersensitivity—Prednisone—psoriasis	3.4e-05	0.000107	CcSEcCtD
Riluzole—Dyspepsia—Methotrexate—psoriasis	3.4e-05	0.000107	CcSEcCtD
Riluzole—Vomiting—Betamethasone—psoriasis	3.37e-05	0.000106	CcSEcCtD
Riluzole—Vomiting—Dexamethasone—psoriasis	3.37e-05	0.000106	CcSEcCtD
Riluzole—Decreased appetite—Methotrexate—psoriasis	3.35e-05	0.000106	CcSEcCtD
Riluzole—Rash—Betamethasone—psoriasis	3.34e-05	0.000105	CcSEcCtD
Riluzole—Rash—Dexamethasone—psoriasis	3.34e-05	0.000105	CcSEcCtD
Riluzole—Dermatitis—Dexamethasone—psoriasis	3.34e-05	0.000105	CcSEcCtD
Riluzole—Dermatitis—Betamethasone—psoriasis	3.34e-05	0.000105	CcSEcCtD
Riluzole—Gastrointestinal disorder—Methotrexate—psoriasis	3.33e-05	0.000105	CcSEcCtD
Riluzole—Fatigue—Methotrexate—psoriasis	3.33e-05	0.000105	CcSEcCtD
Riluzole—Headache—Betamethasone—psoriasis	3.32e-05	0.000105	CcSEcCtD
Riluzole—Headache—Dexamethasone—psoriasis	3.32e-05	0.000105	CcSEcCtD
Riluzole—Asthenia—Prednisone—psoriasis	3.31e-05	0.000104	CcSEcCtD
Riluzole—Pain—Methotrexate—psoriasis	3.3e-05	0.000104	CcSEcCtD
Riluzole—Pruritus—Prednisone—psoriasis	3.27e-05	0.000103	CcSEcCtD
Riluzole—Feeling abnormal—Methotrexate—psoriasis	3.18e-05	0.0001	CcSEcCtD
Riluzole—Diarrhoea—Prednisone—psoriasis	3.16e-05	9.95e-05	CcSEcCtD
Riluzole—Gastrointestinal pain—Methotrexate—psoriasis	3.16e-05	9.94e-05	CcSEcCtD
Riluzole—Nausea—Betamethasone—psoriasis	3.15e-05	9.92e-05	CcSEcCtD
Riluzole—Nausea—Dexamethasone—psoriasis	3.15e-05	9.92e-05	CcSEcCtD
Riluzole—Urticaria—Methotrexate—psoriasis	3.07e-05	9.65e-05	CcSEcCtD
Riluzole—Dizziness—Prednisone—psoriasis	3.05e-05	9.62e-05	CcSEcCtD
Riluzole—Abdominal pain—Methotrexate—psoriasis	3.05e-05	9.61e-05	CcSEcCtD
Riluzole—Body temperature increased—Methotrexate—psoriasis	3.05e-05	9.61e-05	CcSEcCtD
Riluzole—Vomiting—Prednisone—psoriasis	2.94e-05	9.24e-05	CcSEcCtD
Riluzole—Rash—Prednisone—psoriasis	2.91e-05	9.17e-05	CcSEcCtD
Riluzole—Dermatitis—Prednisone—psoriasis	2.91e-05	9.16e-05	CcSEcCtD
Riluzole—Headache—Prednisone—psoriasis	2.89e-05	9.11e-05	CcSEcCtD
Riluzole—Hypersensitivity—Methotrexate—psoriasis	2.84e-05	8.95e-05	CcSEcCtD
Riluzole—Asthenia—Methotrexate—psoriasis	2.77e-05	8.72e-05	CcSEcCtD
Riluzole—Nausea—Prednisone—psoriasis	2.74e-05	8.64e-05	CcSEcCtD
Riluzole—Pruritus—Methotrexate—psoriasis	2.73e-05	8.6e-05	CcSEcCtD
Riluzole—Diarrhoea—Methotrexate—psoriasis	2.64e-05	8.31e-05	CcSEcCtD
Riluzole—Dizziness—Methotrexate—psoriasis	2.55e-05	8.04e-05	CcSEcCtD
Riluzole—Vomiting—Methotrexate—psoriasis	2.45e-05	7.73e-05	CcSEcCtD
Riluzole—Rash—Methotrexate—psoriasis	2.43e-05	7.66e-05	CcSEcCtD
Riluzole—Dermatitis—Methotrexate—psoriasis	2.43e-05	7.65e-05	CcSEcCtD
Riluzole—Headache—Methotrexate—psoriasis	2.42e-05	7.61e-05	CcSEcCtD
Riluzole—Nausea—Methotrexate—psoriasis	2.29e-05	7.22e-05	CcSEcCtD
